Clinical Trial Update: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure [Phase 3]

View source ↗

Summary

Phase III clinical study investigating recombinant erythropoiesis-stimulating protein (rESP) for anemia in patients with chronic kidney disease on hemodialysis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Hemodialysis
• Kidney Failure Chronic

Drugs mentioned

• recombinant erythropoiesis-stimulating protein (erythropoiesis-stimulating protein)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Kidney Failure, Chronic, Hemodialysis | Phase 3 | Status: UNKNOWN